GT Biopharma Inc banner

GT Biopharma Inc
NASDAQ:GTBP

Watchlist Manager
GT Biopharma Inc Logo
GT Biopharma Inc
NASDAQ:GTBP
Watchlist
Price: 0.4457 USD -4.91%
Market Cap: $16.1m

Wall St Price Targets

GTBP Price Targets Summary
GT Biopharma Inc

There are no price targets for GTBP.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
GT Biopharma Inc Competitors:
Price Targets
INBK
First Internet Bancorp
2% Upside
EOLS
Evolus Inc
120% Upside
ANY
ANY Biztonsagi Nyomda Nyrt
0% Upside
ADSK
Autodesk Inc
69% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for GT Biopharma Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GTBP's stock price target?
Not Available

GTBP does not have any price targets made by Wall Street professionals.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett